Genmab | GEN - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Agios Pharmaceuticals USD 979.34M 46.68M 2026-09
Almirall EUR 1.53B 43.26M 2026-06
Amarin USD 444.41M 796K 2026-09
Amgen USD 14.35B 2.66B 2026-09
argenx SE USD 8.42B 1.09B 2026-06
AstraZeneca USD 51.73B 1.43B 2026-09
Bayer EUR 29.18B 533M 2026-09
BioMarin Pharmaceutical USD 6.26B 65.66M 2026-09
Demant DKK 11.24B 1.4B 2026-06
Exelixis USD 1.83B 9.93M 2026-09
Fresenius Medical Care EUR 13.76B 226.23M 2026-09
Genmab DKK 5.96B 275M 2026-06
GlaxoSmithKline GBP 18.75B 1.11B 2026-09
GN Store Nord DKK 10.51B 241M 2026-09
GRIFOLS EUR 5.79B 2.19B 2026-09
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Insmed USD 726.21M 31.28M 2026-09
Lakefront Biotherapeutics EUR 3.26B 10.26M 2026-06
Lonza CHF 9.13B 513M 2025-12
Merck EUR 30.17B 430M 2026-06
Novartis USD 37.23B 4.72B 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 72.88B 3.31B 2026-09
UCB EUR 10.87B 1.18B 2025-12